Not known Facts About Lp-PLA2-IN-1
Contraindicated (1)bortezomib will boost the level or outcome of mavacamten by influencing hepatic enzyme CYP2C19 metabolism. Contraindicated. Potent or average CYP2C19 inhibitors may possibly enhance mavacamten systemic exposure, causing coronary heart failure on account of systolic dysfunction.Important: The drug info on this website page is mean